Perrigo Company PLC (NYSE: PRGO) is a consumer self-care company that develops, manufactures, and sells store-brand over-the-counter health and wellness products. The company generates revenue through transactional product sales, primarily supplying private-label OTC medications and personal care items to retailers who sell them under their own store brands. The 10-K filed 2026-02-26 covers the fiscal year ended December 31, 2025. The filing excerpts provided do not contain sufficient detail to support specific segment revenue figures, customer counts, geographic breakdowns, competitor names, founding year, or leadership details, so those specifics are omitted here in accordance with source-grounding requirements.

Revenue model

The filing excerpts do not provide sufficient detail to describe the revenue model with specific figures or segment breakdowns.

Products and services

The filing excerpts do not provide sufficient product or brand detail to enumerate specific products or services.

Customers and end markets

The filing excerpts do not provide sufficient detail to describe customer concentration, end markets, or customer types.

Value-chain role

The filing excerpts do not provide sufficient detail to describe Perrigo's specific value-chain role.

Geographic exposure

The filing excerpts do not provide sufficient detail to describe geographic revenue mix or operational footprint.

Source: SEC 10-K, filed 2026-02-26

Industry: Pharmaceutical Preparations Peers: AVADEL PHARMACEUTICALS PLC Endo International plc GH Research PLC ITERUM THERAPEUTICS PLC Jazz Pharmaceuticals PLC Keenova Therapeutics plc Nabriva Therapeutics plc